Market Overview

Benzinga's Top Pre-Market Gainers

Related HZNP
Horzion Pharma Presents Results of ACTIMMUNE(R) Phase 2 Data, Says Results Show Statistical Significant
Horizon Pharma Offers Update on Effectiveness of S-4 Registration
Horizon Inks $660M Reverse Merger With Ireland's Vidara (Fox Business)
Related ASCA
Pinnacle Entertainment Closes Purchase of Ameristar
Top 4 Stocks In The Resorts & Casinos Industry With The Highest Dividend Yield

Horizon Pharma (NASDAQ: HZNP) moved up 16.63% to $2.80 in the pre-market session. Horizon Pharma will receive approval of DUEXIS from the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency (MHRA).

Ameristar Casinos (NASDAQ: ASCA) added 16.31% to $25.67 in the pre-market session. Pinnacle Entertainment (NYSE: PNK) announced its plans to buy Ameristar Casinos for around $869 million.

Halozyme Therapeutics (NASDAQ: HALO) surged 14.86% to $6.34 in the pre-market session. Halozyme Therapeutics and Pfizer (NYSE: PFE) entered into a worldwide Collaboration for the purpose of developing and commercializing subcutaneous biologics using recombinant human hyaluronidase.

Red Hat (NYSE: RHT) soared 5.49% to $55.50 in the pre-market trading. Red Hat posted better-than-expected third-quarter revenue and announced its plans to buy privately held ManageIQ for $104 million in cash.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (ASCA + HALO)

Around the Web, We're Loving...

Get Benzinga's Newsletters